Format

Send to:

Choose Destination
See comment in PubMed Commons below
Br J Psychiatry Suppl. 2007 Aug;50:s42-5.

Health economic measures in schizophrenia research.

Author information

  • 1Department of Health Service and Population Research, King's College London, Institute of Psychiatry, UK. p.mccrone@iop.kcl.ac.uk

Abstract

BACKGROUND:

It is essential in economic evaluations of schizophrenia interventions that all relevant costs are identified and measured appropriately. Also of importance is the way in which cost data are combined with information on outcomes.

AIMS:

To examine the use of health economics in evaluations of interventions for schizophrenia.

METHODS:

A review of the key methods used to estimate costs and to linkcosts and outcomes was conducted.

RESULTS:

Costs fall on a number of different agencies and can be short term or long term. Cost-effectiveness analysis and cost-utility analysis are the most appropriate methods for combing cost and outcome data.

CONCLUSIONS:

Schizophrenia poses a number of challenges for economic evaluation.

PMID:
18019043
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk